Nymox Reports on Symposium, Panel Discussion and Podium Presentation on Fexapotide at American Urological Association New York Section Annual Meeting in Havana
November 07, 2017 11:15 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the two data presentations which were held on Fexapotide Triflutate...
Nymox Announces Two Data Presentations for Company's BPH Drug at New York American Urological Association Meeting November 6
October 26, 2017 12:15 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that two data presentations of the Company's new drug Fexapotide...
Nymox Reports on Symposium, Panel Discussion with Abstract on Fexapotide at American Urological Association Northeast Sectional Annual Meeting in Savannah
October 13, 2017 09:37 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Oct. 13, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the Symposium which was held on Fexapotide Triflutate studies at the...
Nymox Reports on Symposium and Panel Discussion on Fexapotide at American Urological Association Northeast Sectional Annual Meeting in Savannah October 12
October 10, 2017 10:00 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the Symposium on Fexapotide Triflutate studies to be held at the...
Nymox Announces October 12 Symposium for Company's BPH Drug at American Urological Association Meeting
September 25, 2017 10:30 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that an important large symposium and panel assessment of the...
Nymox Application Validated:
September 14, 2017 12:39 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce today that the European Member States for Nymox's Marketing...
Nymox Announces New Symposium for Company's BPH Drug at American Urological Association Meeting October 5
September 14, 2017 10:00 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that an important large symposium and panel assessment of the...
AUA Meeting in Florida September 16 Postponed Due to Hurricane
September 11, 2017 12:15 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) The September 16 AUA Meeting in Amelia Island, Florida has been postponed due to the...
Nymox Announces Private Placements of $3 Million
August 09, 2017 10:30 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce recent completion of private placements with proceeds totaling US...
Nymox Announces Symposium for Company's BPH Drug at American Urological Association Meeting in September
August 07, 2017 10:00 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that an important large symposium and panel assessment of the...